These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10023929)

  • 1. Cervical cancer, HPV 16 E6, variant genotypes, and serology.
    Nindl I; Rindfleisch K; Teller K; Schneider A; Dürst M
    Lancet; 1999 Jan; 353(9147):152. PubMed ID: 10023929
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
    Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
    Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Human papillomaviruses].
    Kiyono T
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():562-7. PubMed ID: 12718029
    [No Abstract]   [Full Text] [Related]  

  • 4. Human papillomavirus type 16 intratypic variant infection and risk for cervical neoplasia in southern China.
    Chan PK; Lam CW; Cheung TH; Li WW; Lo KW; Chan MY; Cheung JL; Xu LY; Cheng AF
    J Infect Dis; 2002 Sep; 186(5):696-700. PubMed ID: 12195358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-mutation of HPV16 E6 and E7 genes in Thai squamous cervical carcinomas.
    Vaeteewoottacharn K; Jearanaikoon P; Ponglikitmongkol M
    Anticancer Res; 2003; 23(2C):1927-31. PubMed ID: 12820481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable oncogene promoter activity of human papillomavirus type 16 cervical cancer isolates from Australia.
    Watts KJ; Thompson CH; Cossart YE; Rose BR
    J Clin Microbiol; 2001 May; 39(5):2009-14. PubMed ID: 11326037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective.
    Yamada T; Manos MM; Peto J; Greer CE; Munoz N; Bosch FX; Wheeler CM
    J Virol; 1997 Mar; 71(3):2463-72. PubMed ID: 9032384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference.
    Jiang M; Milner J
    Oncogene; 2002 Sep; 21(39):6041-8. PubMed ID: 12203116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus and cervical carcinogenesis.
    Stanley MA
    Best Pract Res Clin Obstet Gynaecol; 2001 Oct; 15(5):663-76. PubMed ID: 11563866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-time PCR-based fluorescent assay for quantitation of human papillomavirus types 6, 11, 16, and 18.
    Tucker RA; Unger ER; Holloway BP; Swan DC
    Mol Diagn; 2001 Mar; 6(1):39-47. PubMed ID: 11257210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
    López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS
    Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of human papillomaviruses in cancer of the uterine cervix.
    Molendijk LW
    S Afr Med J; 1996 Apr; 86(4):379, 381. PubMed ID: 8693384
    [No Abstract]   [Full Text] [Related]  

  • 14. Human papillomavirus type 16 E6 variants in cervical carcinoma: relationship to host genetic factors and clinical parameters.
    Brady CS; Duggan-Keen MF; Davidson JA; Varley JM; Stern PL
    J Gen Virol; 1999 Dec; 80 ( Pt 12)():3233-3240. PubMed ID: 10567656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins.
    Duensing S; Münger K
    Int J Cancer; 2004 Mar; 109(2):157-62. PubMed ID: 14750163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development.
    Zehbe I; Voglino G; Wilander E; Delius H; Marongiu A; Edler L; Klimek F; Andersson S; Tommasino M
    Cancer Res; 2001 Jan; 61(2):608-11. PubMed ID: 11212257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of HPV-18 and variants of E6 gene isolated from cervical cancer patients in Taiwan.
    Chang CH; Chen TH; Hsu RC; Chou PH; Yang JJ; Hwang GY
    J Clin Virol; 2005 Jan; 32(1):33-7. PubMed ID: 15572004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses.
    Molden T; Kraus I; Skomedal H; Nordstrøm T; Karlsen F
    J Virol Methods; 2007 Jun; 142(1-2):204-12. PubMed ID: 17379322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papillomavirus and p53.
    zur Hausen H
    Nature; 1998 May; 393(6682):217. PubMed ID: 9607756
    [No Abstract]   [Full Text] [Related]  

  • 20. Functional consequences of directed mutations in human papillomavirus E6 proteins: abrogation of p53-mediated cell cycle arrest correlates with p53 binding and degradation in vitro.
    Slebos RJ; Kessis TD; Chen AW; Han SM; Hedrick L; Cho KR
    Virology; 1995 Apr; 208(1):111-20. PubMed ID: 11831691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.